Jay Strum - Net Worth and Insider Trading
Jay Strum Net Worth
The estimated net worth of Jay Strum is at least $347,268 dollars as of 2024-09-20. Jay Strum is the Chief Scientific Officer of G1 Therapeutics Inc and owns about 48,569 shares of G1 Therapeutics Inc (GTHX) stock worth over $347,268. Details can be seen in Jay Strum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay Strum has not made any transactions after 2018-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jay Strum
Jay Strum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jay Strum owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Jay Strum’s form 4 insider trades.
Insider Ownership Summary of Jay Strum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2018-08-30 | Chief Scientific Officer |
Jay Strum Latest Holdings Summary
Jay Strum currently owns a total of 1 stock. Jay Strum owns 48,569 shares of G1 Therapeutics Inc (GTHX) as of August 30, 2018, with a value of $347,268.
Latest Holdings of Jay Strum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2018-08-30 | 48,569 | 7.15 | 347,268 |
Holding Weightings of Jay Strum
Jay Strum Form 4 Trading Tracker
According to the SEC Form 4 filings, Jay Strum has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the sale of 10,000 shares on August 30, 2018, which brought Jay Strum around $596,000.
Insider Trading History of Jay Strum
- 1
Jay Strum Trading Performance
Jay Strum Ownership Network
Jay Strum Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Jay Strum is the Chief Scientific Officer of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Jay Strum made no insider transaction in G1 Therapeutics Inc (GTHX). Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 92,308 shares made by Bailey John E. (jack) Jr. , and a net sale of 15,968 shares made by John V. Umstead .
In summary, during the past 3 months, insiders sold 17,114 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 17,114 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Jay Strum Mailing Address
Above is the net worth, insider trading, and ownership report for Jay Strum. You might contact Jay Strum via mailing address: 79 Tw Alexander Drive, 4501 Research Commons, Suite 100, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
